Samuel Martel

429 total citations
22 papers, 289 citations indexed

About

Samuel Martel is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Samuel Martel has authored 22 papers receiving a total of 289 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 9 papers in Cancer Research. Recurrent topics in Samuel Martel's work include Advanced Breast Cancer Therapies (9 papers), Breast Cancer Treatment Studies (7 papers) and Cancer Risks and Factors (5 papers). Samuel Martel is often cited by papers focused on Advanced Breast Cancer Therapies (9 papers), Breast Cancer Treatment Studies (7 papers) and Cancer Risks and Factors (5 papers). Samuel Martel collaborates with scholars based in Belgium, Canada and Germany. Samuel Martel's co-authors include Matteo Lambertini, Christian Maurer, Evandro de Azambuja, Noam Pondé, Martine Piccart, Lucia Del Mastro, Arlindo R. Ferreira, Marco Bruzzone, Marcello Ceppi and Michail Ignatiadis and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Samuel Martel

20 papers receiving 285 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samuel Martel Belgium 10 221 106 64 63 42 22 289
Furkan Sarici Türkiye 10 263 1.2× 78 0.7× 150 2.3× 93 1.5× 59 1.4× 28 391
Sara Taylor Canada 9 242 1.1× 63 0.6× 123 1.9× 180 2.9× 33 0.8× 16 361
Nicole Williams United States 8 110 0.5× 91 0.9× 36 0.6× 63 1.0× 57 1.4× 17 244
Domenico Ferraioli France 10 135 0.6× 42 0.4× 43 0.7× 117 1.9× 17 0.4× 27 314
Francesca De Iuliis Italy 9 198 0.9× 64 0.6× 52 0.8× 58 0.9× 24 0.6× 17 317
Nicoletta Provinciali Italy 9 175 0.8× 54 0.5× 119 1.9× 83 1.3× 48 1.1× 22 308
Artur M Burylo Netherlands 8 206 0.9× 52 0.5× 58 0.9× 137 2.2× 11 0.3× 10 303
Jan C. Drooger Netherlands 11 125 0.6× 45 0.4× 60 0.9× 58 0.9× 67 1.6× 19 243
M.M. Boisen United States 13 70 0.3× 47 0.4× 46 0.7× 101 1.6× 39 0.9× 45 401
Jennifer Kherani United States 10 113 0.5× 104 1.0× 45 0.7× 65 1.0× 21 0.5× 19 241

Countries citing papers authored by Samuel Martel

Since Specialization
Citations

This map shows the geographic impact of Samuel Martel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel Martel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel Martel more than expected).

Fields of papers citing papers by Samuel Martel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel Martel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel Martel. The network helps show where Samuel Martel may publish in the future.

Co-authorship network of co-authors of Samuel Martel

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel Martel. A scholar is included among the top collaborators of Samuel Martel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel Martel. Samuel Martel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maurer, Christian, Elisa Agostinetto, Lieveke Ameye, et al.. (2025). Association of statin use on survival outcomes of patients with early-stage HER2-positive breast cancer in the APHINITY trial. Breast Cancer Research and Treatment. 212(1). 57–69. 1 indexed citations
2.
Franzoi, Maria Alice, Samuel Martel, Dominique Agbor‐Tarh, et al.. (2025). Body mass index and weight changes in patients with HER2-positive early breast cancer: A sub-analysis of the APHINITY trial. European Journal of Cancer. 223. 115489–115489. 3 indexed citations
3.
Lohmann, Ana Elisa, Marguerite Ennis, Pamela J. Goodwin, et al.. (2023). Concordance between liquid and tissue biopsy in participants with newly diagnosed recurrent breast cancer.. Journal of Clinical Oncology. 41(16_suppl). 1028–1028. 1 indexed citations
4.
Agostinetto, Elisa, Lieveke Ameye, Samuel Martel, et al.. (2022). PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer. npj Breast Cancer. 8(1). 87–87. 9 indexed citations
5.
Martel, Samuel, Matteo Lambertini, Dominique Agbor‐Tarh, et al.. (2021). Body Mass Index and Weight Change in Patients With HER2-Positive Early Breast Cancer: Exploratory Analysis of the ALTTO BIG 2-06 Trial. Journal of the National Comprehensive Cancer Network. 19(2). 181–189. 19 indexed citations
6.
Agostinetto, Elisa, Lieveke Ameye, Samuel Martel, et al.. (2021). The prognostic performance of PREDICT+ in patients (pts) with HER2-positive (HER2+) early-stage breast cancer (EBC).. Journal of Clinical Oncology. 39(15_suppl). 524–524. 1 indexed citations
7.
Brandão, Mariana, Christian Maurer, Patrícia Klarmann Ziegelmann, et al.. (2020). Endocrine therapy-based treatments in hormone receptor-positive/HER2-negative advanced breast cancer: systematic review and network meta-analysis. ESMO Open. 5(4). e000842–e000842. 25 indexed citations
8.
Ferreira, Arlindo R., Sofia Cristóvão‐Ferreira, Matteo Lambertini, et al.. (2020). Association between pertuzumab-associated diarrhoea and rash and survival outcomes in patients with HER2-positive metastatic breast cancer: Exploratory analysis from the CLEOPATRA trial. European Journal of Cancer. 144. 351–359. 1 indexed citations
9.
Poggio, Francesca, Marco Bruzzone, Marcello Ceppi, et al.. (2018). Single-agent PARP inhibitors for the treatment of patients with BRCA-mutated HER2-negative metastatic breast cancer: a systematic review and meta-analysis. ESMO Open. 3(4). e000361–e000361. 47 indexed citations
10.
Martel, Samuel, et al.. (2018). Adherence to Guidelines in Requesting Oncotype DX in a Publicly Funded Health Care System. Current Oncology. 25(4). 311–318.
11.
12.
Maurer, Christian, Arlindo R. Ferreira, Samuel Martel, et al.. (2018). Endocrine therapy and palbociclib within a compassionate use program in heavily pretreated hormone receptor-positive, HER2-negative metastatic breast cancer. The Breast. 39. 14–18. 11 indexed citations
13.
Ignatiadis, Michail, Mariana Brandão, Marion Maetens, et al.. (2018). Neoadjuvant biomarker research study of palbociclib combined with endocrine therapy in estrogen receptor positive/HER2 negative breast cancer: The phase II NeoRHEA trial. Annals of Oncology. 29. viii57–viii57.
14.
Martel, Samuel, Matteo Lambertini, Dominique Agbor‐Tarh, et al.. (2018). Impact of body mass index (BMI) and weight change after treatment in patients (pts) with HER2-positive (HER2+) early breast cancer (EBC): Secondary analysis of the ALTTO BIG 2-06 trial.. Journal of Clinical Oncology. 36(15_suppl). 10067–10067. 2 indexed citations
15.
Martel, Samuel, Marco Bruzzone, Marcello Ceppi, et al.. (2017). Risk of adverse events with the addition of targeted agents to endocrine therapy in patients with hormone receptor-positive metastatic breast cancer: A systematic review and meta-analysis. Cancer Treatment Reviews. 62. 123–132. 17 indexed citations
16.
Maurer, Christian, Samuel Martel, Dimitrios Zardavas, & Michail Ignatiadis. (2017). New agents for endocrine resistance in breast cancer. The Breast. 34. 1–11. 15 indexed citations
17.
Maurer, Christian, Samuel Martel, & Evandro de Azambuja. (2017). Male breast cancer: finding the way in this uncommon path. ESMO Open. 2(1). e000169–e000169. 1 indexed citations
18.
Martel, Samuel, Elena Poletto, Arlindo R. Ferreira, et al.. (2017). Impact of body mass index on the clinical outcomes of patients with HER2-positive metastatic breast cancer. The Breast. 37. 142–147. 27 indexed citations
19.
Martel, Samuel, Christian Maurer, Matteo Lambertini, Noam Pondé, & Evandro de Azambuja. (2017). Breast cancer treatment-induced cardiotoxicity. Expert Opinion on Drug Safety. 16(9). 1021–1038. 51 indexed citations
20.
Martel, Samuel, et al.. (2014). Paraneoplastic neurologic syndromes: Clinical presentation and management. Current Problems in Cancer. 38(4). 115–134. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Furkan Sarici Breakdown of academic impact, for papers by Sara Taylor Breakdown of academic impact, for papers by Nicole Williams Breakdown of academic impact, for papers by Domenico Ferraioli Breakdown of academic impact, for papers by Francesca De Iuliis Breakdown of academic impact, for papers by Nicoletta Provinciali Breakdown of academic impact, for papers by Artur M Burylo Breakdown of academic impact, for papers by Jan C. Drooger Breakdown of academic impact, for papers by M.M. Boisen Breakdown of academic impact, for papers by Jennifer Kherani
Rankless by CCL
2026